|
|
???tair.name??? >
???browser.page.title.author???
|
"lee kw"???jsp.browse.items-by-author.description???
Showing items 1-25 of 45 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2022-02 |
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-contr
|
Kang, YK;Chen, LT;Ryu, MH;Oh, DY;Oh, SC;Chung, HC;Lee, KW;Omori, T;Shitara, K;Sakuramoto, S;Chung, IJ;Yamaguchi, K;Kato, K;Sym, SJ;Kadowaki, S;Tsuji, K;Chen, JS;Bai, LY;Oh, SY;Choda, Y;Yasui, H;Takeuchi, K;Hirashima, Y;Hagihara, S;Boku, N |
| 國家衛生研究院 |
2021-09-04 |
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: Post hoc subanalysis from the ATTRACTION-2 study
|
Kang, YK;Morita, S;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Sameshima, H;Chen, LT;Boku, N |
| 國家衛生研究院 |
2021-03-20 |
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
|
Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Nishiyama, T;Chen, LT;Kang, YK |
| 國家衛生研究院 |
2020-09 |
Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
|
Boku, N;Ryu, MH;Oh, DY;Oh, SC;Chung, HC;Lee, KW;Omori, T;Shitara, K;Sakuramoto, S;Chung, IJ;Yamaguchi, K;Kato, K;Sym, SJ;Kadowaki, S;Tsuji, K;Chen, JS;Bai, LY;Chen, LT;Kang, YK |
| 國家衛生研究院 |
2020-02 |
A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data
|
Chen, LT;Kang, YK;Satoh, T;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, W;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Boku, N |
| 國家衛生研究院 |
2019-12-20 |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
|
Chen, LT;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Sameshima, H;Kang, YK;Boku, N |
| 國家衛生研究院 |
2019-05-13 |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: A randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh, T;Kang, YK;Chao, Y;Ryu, MH;Kato, K;Cheol Chung, H;Chen, JS;Muro, K;Ki Kang, W;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Tanimoto, M;Chen, LT;Boku, N |
| 國家衛生研究院 |
2019-02 |
Evaluation of efficacy of nivolumab by baseline factors from ATTRACTION-2
|
Kang, YK;Satoh, T;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Morita, S;Chen, LT;Boku, N |
| 國家衛生研究院 |
2018-12-19 |
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase 2 trial (AT
|
Boku, N;Ryu, MH;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Chen, LT;Kang, YK |
| 國家衛生研究院 |
2017-12 |
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Kang, YK;Boku, N;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yeh, KH;Yoshikawa, T;Oh, SC;Bai, LY;Tamura, T;Lee, KW;Hamamoto, Y;Kim, JG;Chin, K;Oh, DY;Minashi, K;Cho, JY;Tsuda, M;Chen, LT |
| 國家衛生研究院 |
2017-09 |
Interim safety and clinical activity of nivolumab (Nivo) in combination with S-1/capecitabine plus oxaliplatin in patients (pts) with previously untreated unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: part 1 study of ATTRACTION-04 (ONO-4538-37)
|
Kang, YK;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Boku, N;Chen, LT |
| 國家衛生研究院 |
2017-09 |
A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02)
|
Boku, N;Kang, YK;Satoh, T;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Chen, LT |
| 國家衛生研究院 |
2017-02 |
Nivolumab (ONO-4538/BMS-936558) as salvage treatment after second or later-line chemotherapy for advanced gastric or gastroesophageal junction cancer (AGC): A double-blinded, randomized, phase III trial
|
Kang, YK;Satoh, T;Ryu, MH;Chao, Y;Kato, K;Chung, HC;Chen, JS;Muro, K;Kang, WK;Yoshikawa, T;Oh, SC;Tamura, T;Lee, KW;Boku, N;Chen, LT |
| 國家衛生研究院 |
2015-08 |
Analysis of differentially expressed novel post-translational modifications of plasma apolipoprotein E in Taiwanese females with breast cancer
|
Uen, YH;Liao, CC;Lin, JC;Pan, YH;Liu, YC;Chen, YC;Chen, WJ;Tai, CC;Lee, KW;Liu, YR;Lin, HT;Lin, CY |
| 國立交通大學 |
2014-12-08T15:41:01Z |
Liquid phase deposited SiO2 on GaN
|
Wu, HR; Lee, KW; Nian, TB; Chou, DW; Wu, JJH; Wang, YH; Houng, MP; Sze, PW; Su, YK; Chang, SJ; Ho, CH; Chiang, CI; Chern, YT; Juang, FS; Wen, TC; Lee, WI; Chyi, JI |
| 國立交通大學 |
2014-12-08T15:16:33Z |
Synthesis and characterization of rod-coil polymers based on poly(ethylene oxide)s sand novel luminescent aromatic cores
|
Lin, HC; Lee, KW; Tsai, CM; Wei, KH |
| 國家衛生研究院 |
2013-09-27 |
Structure of native oligomeric Sprouty2 by electron microscopy and its property of electroconductivity
|
Chen, FJ;Lee, KW;Lai, CC;Lee, SP;Shen, HH;Tsai, SP;Liu, BH;Wang, LM;Liou, GG |
| 國家衛生研究院 |
2013-04 |
Changes in the genome-wide localization pattern of Sir3 in Saccharomyces cerevisiae during different growth stages
|
Tung, SY;Lee, KW;Hong, JY;Lee, SP;Shen, HH;Liou, GG |
| 臺北醫學大學 |
2013 |
omparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer
|
Uen, YH;Lin, KY;Sun, DP;Liao, CC;Hsieh, MS;Huang, YK;Chen, YW;Huang, PH;Chen, WJ;Tai, CC;Lee, KW;Chen, YC;Lin, CY |
| 高雄醫學大學 |
2012 |
Head and neck extranodal lymphoma in a single institute: A 17-year retrospective analysis.
|
Chi, HS;李家和;江豐裕;戴志峰;王凌峰;楊曉芳;林勝豐;郭文烈 ; Chi, HS;Lee, KW;Chiang, FY;Tai, CF;Wang, LF;Yang, SF;Lin, SF;Kuo, WR |
| 國家衛生研究院 |
2011 |
Primary adipose-derived stem cells enriched by growth factor treatment improves cell adaptability toward cardiovascular differentiation in a rodent model of acute myocardial infarction
|
Chang, JC;Lee, PC;Lin, YC;Lee, KW;Hsu, SH |
| 高雄醫學大學 |
2011 |
無菸檳榔結合酒精與菸草之使用影響上氣消化道癌症之腫瘤發生年齡的作用
|
李建宏;李家和;方富民;吳登強;謝天渝;黃曉靈;陳中和;陳丙何;陳穆寬;郭守仁;張丞賢;蔡易珊;蔣尚倫;杜鴻賓;陳百薰;葛應欽; Lee, CH;Lee, KW;Fang, FM;Wu, DC;Shieh, TY;Huang, HL;Chen, CH;Chen, PH;Chen, MK;Kuo, SJ;Chang, CH;Tsai, YS;Chiang, SL;Tu, HP;Chen, BH;Ko, YC |
| 國家衛生研究院 |
2010-04 |
Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: Implication for carcinogenesis
|
Wang, YC;Tsai, YS;Huang, JL;Lee, KW;Kuo, CC;Wang, CS;Huang, AM;Chang, JY;Jong, YJ;Lin, CS |
| 高雄醫學大學 |
2010 |
低量的ATM mRNA表現可作為咽喉癌病人預後不佳的危險標記
|
李家和;蔡易珊;江豐裕;黃昭菱;何坤堯;楊奕馨;郭文烈;陳穆寬;林常申; Lee KW;Tsai YS;Chiang FY;Huang JL;Ho KY;Yang YH;Kuo WR;Chen MK;Lin CS |
| 高雄醫學大學 |
2010 |
Lower mRNA Expression of Ataxia Telangiectasia Mutated (ATM) Gene Predicts Poorer Outcome in Laryngeal and Pharyngeal Cancers
|
李家和;蔡易珊;江豐裕;黃昭菱;何坤堯;楊奕馨;郭文烈;陳穆寬;林常申; Lee, KW;Tsai, YS;Chiang, FY;Huang, JL;Ho, KY;Yang, YH;Kuo, WR;Chen, MK;Lin, CS |
Showing items 1-25 of 45 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
